Stockreport

Kelyniam Global Reports 2025 Financial Results

KELYNIAM GLOBAL INC  (KLYG) 
PDF Strong Second-Half Momentum Drives 85% Net Loss Improvement; FDA Clearance Secured for Innovative Fusion™ Biomaterial Implant; Board Rejects Undervalued Acquisition Inte [Read more]